Cytokine-Based Cancer Immunotherapies Summit

Kongressthemen
This is the primary industry platform dedicated to providing you insight into the latest clinical results and stimulating discussions around
how to take cytokine-based immunotherapy combinations forward.

The renewed interest in the anti-tumor properties of cytokines has led to an increase in the number of clinical trials that explore the safety and efficacy of cytokine-based drugs, not only as single agents, but also in combination with other immunomodulatory drugs.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/708655-2?pid=4832

Speakers: Ruth Ganss, Professor in Translational Cancer Research, Harry Perkins Institute of Medical Research, University of Western Australia, and more.

https://go.evvnt.com/708655-1?pid=4832

Herr Customer Services